Long-Term Efficacy Outcomes of Natalizumab vs. Fingolimod in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis: Real-World Data From a Multiple Sclerosis Reference...

por Boziki, Marina, Bakirtzis, Christos, Giantzi, Virginia, Sintila, Styliani-Aggeliki, Kallivoulos, Stylianos, Afrantou, Theodora, Nikolaidis, Ioannis, Ioannidis, Panagiotis, Karapanayiotides, Theodoros, Koutroulou, Ioanna, Parissis, Dimitrios, Grigoriadis, Nikolaos
Publicado 2021